Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 3Radiation Injuries 1Prostatic Neoplasms 1Neoplasms, Second Primary 1Lung Neoplasms 1Head and Neck Neoplasms 1Eye Diseases 1Colorectal Neoplasms 1Cognitive Dysfunction 1Cardiovascular Diseases 1

Interventions

Radiotherapy 29Cisplatin 12Amifostine 11Radiotherapy, Intensity-Modulated 7Paclitaxel 7Carboplatin 7Etoposide 5Radiosurgery 4Donepezil 4Brachytherapy 4Bevacizumab 4sargramostim 3Surgical Procedures, Operative 3Mental Status and Dementia Tests 3Filgrastim 3Diet Therapy 3Blood Specimen Collection 3Radiation Dose Hypofractionation 2Radiation 2Proton Therapy 2Magnetic Resonance Spectroscopy 2Low-Level Light Therapy 2Lithium 2Hyperbaric Oxygenation 2Heavy Ion Radiotherapy 2Fluorouracil 2Fibroblast Growth Factor 7 2Dexamethasone 2Chemotherapy, Adjuvant 2Androgen Antagonists 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Radiation Injuries × beta Carotene × Clear all
NCT00169845 2018-03-14

Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients

Laval University

Phase 3 Completed
540 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms, Radiation Injuries, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡